Verrica Pharmaceuticals Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Verrica Pharmaceuticals Inc. reported Cash And Cash Equivalents At Carrying Value of $30.15 million for the year ending 2025.

  • Verrica Pharmaceuticals Inc. showed a decrease of -34.9% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Verrica Pharmaceuticals Inc.'s annual report (Form 10-K), filed with the SEC on March 11, 2026.
  • XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 10 years of available data (2016 to 2025), Verrica Pharmaceuticals Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 5,620.5%.
  • Historical annual values: Fiscal year 2025: $30.15 million | Fiscal year 2024: $46.33 million | Fiscal year 2023: $69.55 million | Fiscal year 2022: $34.27 million | Fiscal year 2021: $15.75 million | Fiscal year 2020: $10.69 million | Fiscal year 2019: $9.24 million | Fiscal year 2018: $10.27 million | Fiscal year 2017: $8.66 million | Fiscal year 2016: $527.0 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: